Net Purchase Price. The Note carries a twenty percent (20%) original issue discount (“OID”). In addition, the Company agrees to pay $200,000 to the Buyer to cover the Buyer’s legal fees, accounting costs, due diligence, monitoring and other transaction costs incurred in connection with the purchase and sale of the Purchased Securities (the “Transaction Expenses”). The Transaction Expenses shall be withheld by the Buyer at the Closing. Accordingly, the “Net Purchase Price” shall be $540,000.00, computed as follows: $925,000.00 less the OID less the Transaction Expenses.
Appears in 1 contract
Sources: Note and Warrant Purchase Agreement (RADIENT PHARMACEUTICALS Corp)
Net Purchase Price. The Note carries a twenty percent (20%) an original issue discount of $10,222.50 (the “OID”). In addition, the Company agrees to pay $200,000 5,000 to the Buyer to cover the Buyer’s legal fees, accounting costs, due diligence, monitoring and other transaction costs incurred in connection with the purchase and sale of the Purchased Securities Notes (the “Transaction Expenses”). The Transaction Expenses shall be withheld by added to the Buyer at principal balance of the Closing. Accordingly, Note such that the “Net Purchase Price” shall be $540,000.0034,075.00, computed as follows: $925,000.00 49,297.50 less the OID less the Transaction Expenses.
Appears in 1 contract